For RSV Antibody In Short Supply, CDC Advises Physicians To Prioritize Babies At Highest Risk Of Disease

The AP (10/24, Stobbe) reports, “A new shot for infants against RSV is in short supply, and U.S. health officials told doctors they should prioritize giving the drug to babies at the highest risk of severe disease.” This includes “infants less than 6 mont...